Shire Provides Results For Phase 3b Vyvanse Study Pharmaceutical Business Review Vyvanse is currently approved by the FDA for the treatment of ADHD in children age 6 to 12 years and in adults with ADHD. The study supports the results of ... VYVANSE CII Provided Significant Efficacy At 14 Hours After ... Medical News Today (press release) all 3 news articles »

By MATTHEW PERRONE The Associated Press Federal health regulators are urging parents to keep their children on attention deficit drugs like Ritalin and Adderall, despite new evidence from a government-backed study that the stimulants can increase the risk of sudden death.

Last week I got an e-mail blast from the FDA. Yet another FDA-approved drug is causing problems. And this time, it‘s a class of drugs prescribed to millions of kids and adults across the country. But they might not be as safe as we‘ve been led to believe. In fact, a new study published in the American Journal of Psychiatry suggests that these drugs may actually increase a child‘s risk of dying suddenly by 500 percent! But the FDA is already backpedaling, due in no small part to enormous pressu

I came across this site 24-7 News that reports another case of Gynecomastia being caused by prescription drugs. This time the culprit is Risperdal. Which has been approved by the FDA, but is being prescribed “off label”, uses that it was not intended or approved for, by some doctors to treat behavioral problems like Attention Deficit Hyperactivity Disorder (ADHD). It was reported that many of the cases were permanent and the boys had to under go breast reduction surgery to correct the proble

A recent study published in The American Journal of Psychiatry got everyone’s attention when it suggested that there may be an “association” between the use of stimulant medications, such as Ritalin, and “sudden cardiac deaths” in children that were considered to be “healthy” prior to their deaths. But the details of the study, along with the “limitations” of the study, prompted the FDA to comment on the research and its conclusions, recommending that parents should not stop giving stimula